<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01482585</url>
  </required_header>
  <id_info>
    <org_study_id>SMC 2011-09-083</org_study_id>
    <nct_id>NCT01482585</nct_id>
  </id_info>
  <brief_title>Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy</brief_title>
  <official_title>Prospective Study of Early-stage Lung Adenocarcinoma for Early Detection and Effective Treatment Strategy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Samsung Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Korean Foundation for Cancer Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Samsung Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      to determine the values of imaging and genetic biomarkers for prediction of tumor
      aggressiveness and prognosis in patient with early stage lung adenocarcinoma to Identify
      unique copy number alteration in patient with early stage lung adenocarcinoma to evaluate the
      long-term change of ground-glass nodule combined with lung adenocarcinoma to suggest a
      guideline for planning an appropriate follow-up examination and management
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2011</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prediction of tumor aggressiveness</measure>
    <time_frame>five years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>prognosis of early stage lung adenocarcinoma following operation</measure>
    <time_frame>five years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Lung Adenocarcinoma</condition>
  <arm_group>
    <arm_group_label>early stage lung adenocarcinoma</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CT, PET, copy number alteration</intervention_name>
    <description>Duel-energy CT, PET, copy number alteration</description>
    <arm_group_label>early stage lung adenocarcinoma</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      lung tissue, serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients with stage I or II lung adenocarcinoma who plans curative operation
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  A. Clinically and radiologically suspected lung adenocarcinoma

          -  B. Newly-diagnosed Stage I or II from the clinical work up including PET/CT

          -  C. Performance status of 0 to 1 on the ECOG scale

          -  D. Age 20 years or older

          -  E. Able to tolerable DECT imaging required by protocol

          -  F. Able to give study-specific informed consent

        Exclusion Criteria:

          -  A. Prior malignancy

          -  B. planning of Definitive RTx ë‚˜ neoadjuvant CCRTx

          -  C. Poor cardiopulmonary reserve
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Young Mog Shim, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Samsung Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Young Mog Shim, Dr.</last_name>
    <email>youngmog.shim@samsung.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ho Yun Lee, Dr.</last_name>
    <email>hoyunlee96@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lee</last_name>
      <email>hj0503.lee@samsung.com</email>
    </contact>
    <investigator>
      <last_name>Young Mog Shim, Dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>November 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2011</study_first_submitted>
  <study_first_submitted_qc>November 29, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2011</study_first_posted>
  <last_update_submitted>November 29, 2011</last_update_submitted>
  <last_update_submitted_qc>November 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 30, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>lung adenocarcinoma</keyword>
  <keyword>prognosis</keyword>
  <keyword>tumor aggressiveness</keyword>
  <keyword>imaging biomarker</keyword>
  <keyword>genetic biomarker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

